Publication date: Oct 11, 2024
In Huntington’s disease (HD), aberrant processing of huntingtin (HTT) mRNA produces HTT1a transcripts that encode the pathogenic HTT exon 1 protein. The mechanisms behind HTT1a production are not fully understood. Considering the role of mA in RNA processing and splicing, we investigated its involvement in HTT1a generation. Here, we show that mA methylation is increased before the cryptic poly(A) sites (IpA1 and IpA2) within the huntingtin RNA in the striatum of Hdh+/Q111 mice and human HD samples. We further assessed mA’s role in mutant Htt mRNA processing by pharmacological inhibition and knockdown of METTL3, as well as targeted demethylation of Htt intron 1 using a dCas13-ALKBH5 system in HD mouse cells. Our data reveal that Htt1a transcript levels are regulated by both METTL3 and the methylation status of Htt intron 1. They also show that mA methylation in intron 1 depends on expanded CAG repeats. Our findings highlight a potential role for mA in aberrant splicing of Htt mRNA.
Open Access PDF
| Concepts | Keywords |
|---|---|
| Huntingtin | HTT1a |
| Mrna | Huntington’s Disease |
| Mutant | m6A |
| Pathogenic | RNA Editing |
| Pharmacological | Splicing |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | Huntington’s disease |
| pathway | REACTOME | Methylation |